Literature DB >> 9279936

Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat.

B Buwalda1, S F de Boer, A A Van Kalkeren, J M Koolhaas.   

Abstract

The present study was conducted to investigate the long-term effects of chronic elevation of centrally circulating levels of corticotropin-releasing factor (CRF) on behavior and physiology. For this purpose ovine CRF was infused continuously for a period of 10 days into the lateral ventricle of rats with the aid of osmotic pumps (calculated CRF delivery was 4.9 micrograms/day). Changes in daily rhythms in body temperature and home cage motor activity were recorded telemetrically during the infusion period. The most prominent physiological findings were a delayed body weight gain and a long-lasting hyperthermia following CRF infusion. The peptide treatment furthermore increased adrenal weight and suppressed the weight of the thymus at the end of the experiment. Behaviorally, CRF administration elicited a short-lasting increase in activity during the light phase and an increased anxiety in an elevated plus-maze 1 week after the start of infusion. The similarities between the present results and the long-term changes previously described in behaviorally stressed rats indicate that chronically elevated levels of CRF in the brain might play an important role in the induction and persistence of stress-related behavioral and physiological disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279936     DOI: 10.1016/s0306-4530(97)00032-2

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  21 in total

1.  Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis.

Authors:  Kendall M Carlin; Wylie W Vale; Tracy L Bale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 2.  Sex-specific effects of relaxin-3 on food intake and body weight gain.

Authors:  Juliane Calvez; Camila de Ávila; Elena Timofeeva
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

3.  Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats.

Authors:  Avdesh Avdesh; Vincent Cornelisse; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

4.  Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.

Authors:  Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2011-05-26       Impact factor: 4.905

5.  Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas.

Authors:  Damián Refojo; Carlos Echenique; Marianne B Müller; Johannes M H M Reul; Jan M Deussing; Wolfgang Wurst; Inge Sillaber; Marcelo Paez-Pereda; Florian Holsboer; Eduardo Arzt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

6.  The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.

Authors:  Christian Grillon; Elizabeth Hale; Lynne Lieberman; Andrew Davis; Daniel S Pine; Monique Ernst
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

7.  Leucine deprivation stimulates fat loss via increasing CRH expression in the hypothalamus and activating the sympathetic nervous system.

Authors:  Ying Cheng; Qian Zhang; Qingshu Meng; Tingting Xia; Zhiying Huang; Chunxia Wang; Bin Liu; Shanghai Chen; Fei Xiao; Ying Du; Feifan Guo
Journal:  Mol Endocrinol       Date:  2011-06-30

8.  Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats.

Authors:  Melanie Felies; Stephan von Hörsten; Reinhard Pabst; Heike Nave
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

9.  Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors.

Authors:  K S Sink; A Chung; K J Ressler; M Davis; D L Walker
Journal:  Behav Brain Res       Date:  2013-02-01       Impact factor: 3.332

10.  17Beta-oestradiol modulates glucocorticoid, neural and behavioural adaptations to repeated restraint stress in female rats.

Authors:  P Lunga; J Herbert
Journal:  J Neuroendocrinol       Date:  2004-09       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.